Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Recombinant Isocitrate Dehydrogenase 1, Soluble (IDH1) | Login | Recombinant Isocitrate Dehydrogenase 1, Soluble (IDH1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Isocitrate Dehydrogenase 1, Soluble (IDH1) | Login | Recombinant Isocitrate Dehydrogenase 1, Soluble (IDH1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant p21 Protein Activated Kinase 4 (PAK4) | Login | Recombinant p21 Protein Activated Kinase 4 (PAK4) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Preferentially Expressed Antigen In Melanoma (PRAME) | Login | Recombinant Preferentially Expressed Antigen In Melanoma (PRAME) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant B-Cell CLL/Lymphoma 2 Like Protein 2 (Bcl2L2) | Login | Recombinant B-Cell CLL/Lymphoma 2 Like Protein 2 (Bcl2L2) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant B-Cell CLL/Lymphoma 2 Like Protein 2 (Bcl2L2) | Login | Recombinant B-Cell CLL/Lymphoma 2 Like Protein 2 (Bcl2L2) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Mindbomb Homolog 1 (MIB1) | Login | Recombinant Mindbomb Homolog 1 (MIB1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant V-Myc Myelocytomatosis Viral Oncogene Homolog 1, Lung Carcinoma Derived (MYCL1) | Login | Recombinant V-Myc Myelocytomatosis Viral Oncogene Homolog 1, Lung Carcinoma Derived (MYCL1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant B-Cell CLL/Lymphoma 2 Like Protein 2 (Bcl2L2) | Login | Recombinant B-Cell CLL/Lymphoma 2 Like Protein 2 (Bcl2L2) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant AXL Receptor Tyrosine Kinase (AXL) | Login | Recombinant AXL Receptor Tyrosine Kinase (AXL) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Abl Interactor 1 (ABI1) | Login | Recombinant Abl Interactor 1 (ABI1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Cancer/Testis Antigen 1B (CTAG1B) | Login | Recombinant Cancer/Testis Antigen 1B (CTAG1B) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Bridging Integrator 2 (BIN2) | Login | Recombinant Bridging Integrator 2 (BIN2) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Pituitary Tumor Transforming 1 Interacting Protein (PTTG1IP) | Login | Recombinant Pituitary Tumor Transforming 1 Interacting Protein (PTTG1IP) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Pregnancy Specific Beta-1-Glycoprotein 2 (PSG2) | Login | Recombinant Pregnancy Specific Beta-1-Glycoprotein 2 (PSG2) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Melanoma Inhibitory Activity Protein 1 (MIA1) | Login | Recombinant Melanoma Inhibitory Activity Protein 1 (MIA1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Bcl2/Adenovirus E1B 19kDa Interacting Protein 3 (BNIP3) | Login | Recombinant Bcl2/Adenovirus E1B 19kDa Interacting Protein 3 (BNIP3) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Transforming Growth Factor Beta 1 Induced Transcript 1 (TGFb1I1) | Login | Recombinant Transforming Growth Factor Beta 1 Induced Transcript 1 (TGFb1I1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Transforming Growth Factor Beta 1 Induced Transcript 1 (TGFb1I1) | Login | Recombinant Transforming Growth Factor Beta 1 Induced Transcript 1 (TGFb1I1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant TXK Tyrosine Kinase (TXK) | Login | Recombinant TXK Tyrosine Kinase (TXK) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Isocitrate Dehydrogenase 1, Soluble (IDH1) | Login | Recombinant Isocitrate Dehydrogenase 1, Soluble (IDH1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Mesothelin (MSLN) | Login | Recombinant Mesothelin (MSLN) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Mesothelin (MSLN) | Login | Recombinant Mesothelin (MSLN) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Preferentially Expressed Antigen In Melanoma (PRAME) | Login | Recombinant Preferentially Expressed Antigen In Melanoma (PRAME) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant V-Ki-Ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) | Login | Recombinant V-Ki-Ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) | ||||||||||||||||
|
||||||||||||||||||


